Thomas A. Mace

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 17 papers. Top paper: “Pancreatic Cancer–Induced Cachexia and Relevant Mouse Models”.

Pancreatic Cancer–Induced Cachexia and Relevant Mouse Models

Pancreas(2018)10.1097/mpa.0000000000001124

N/A

2.2DataRank · unranked

55 citations

Neil Makhijani, Thomas A. Mace, Sally E. Henderson

Dual blockade of IL-6 and CTLA-4 regresses pancreatic tumors in a CD4 + T cell-dependent manner

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.02.07.939199

N/A

0.241DataRank · unranked

4 citations

Christopher McQuinn, Mohammad Y. Zaidi, Hannah M. Knochelmann, Thomas A. Mace, Zhengjia Chen +12 more

Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not Chemoimmunotherapy

Clinical Lung Cancer(2022)10.1016/j.cllc.2021.12.010

N/A

0DataRank · unranked

44 citations

Lai Wei, Sandip H. Patel, Gabrielle Lopez, Madison Grogan, Mingjia Li +17 more

Nucleoside transporters and immunosuppressive adenosine signaling in the tumor microenvironment: Potential therapeutic opportunities

Pharmacology & Therapeutics(2022)10.1016/j.pharmthera.2022.108300

N/A

0DataRank · unranked

27 citations

Brenna Weadick, Thomas A. Mace, Kajal Desai, Hannah Odom, Rajgopal Govindarajan +1 more

Risk factors and predictors of immune-related adverse events: implications for patients with non-small cell lung cancer

Expert Review of Anticancer Therapy(2022)10.1080/14737140.2022.2094772

N/A

0DataRank · unranked

14 citations

Joy Tang, Yizhen Guo, Christopher C. Coss, Thomas A. Mace, Jason J. Bischof +4 more

The phase 1/2 trial of indomethacin in chronic pancreatitis (The PAIR trial): Protocol for a parallel multi-center randomized controlled trial

Pancreatology(2022)10.1016/j.pan.2022.12.008

N/A

0DataRank · unranked

10 citations

Darwin L. Conwell, Liang Li, Alejandra Cervantes, Phil A. Hart, Zobeida Cruz‐Monserrate +9 more

Dual IL-6 and CTLA-4 blockade regresses pancreatic tumors in a T cell– and CXCR3-dependent manner

JCI Insight(2023)10.1172/jci.insight.155006

N/A

0DataRank · unranked

39 citations

Maggie Phillips, Christopher McQuinn, Mohammad Y. Zaidi, Hannah M. Knochelmann, Emily R. Greene +16 more

Suppressive myeloid cells are expanded by biliary tract cancer-derived cytokines in vitro and associate with aggressive disease

British Journal of Cancer(2020)10.1038/s41416-020-1018-0

N/A

0DataRank · unranked

9 citations

Mohammad Y. Zaidi, Jennifer Yang, Michael K. Turgeon, Alyssa M. Krasinskas, Thomas A. Mace +14 more

BTK inhibition potentiates anti-PD-L1 treatment in murine melanoma: potential role for MDSC modulation in immunotherapy

Cancer Immunology Immunotherapy(2023)10.1007/s00262-023-03497-1

N/A

0DataRank · unranked

15 citations

Colin D. Angell, Himanshu Savardekar, Debasish Sundi, David Abood, Brooke Benner +15 more

Antibody Drug Clearance: An Underexplored Marker of Outcomes with Checkpoint Inhibitors

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1683

N/A

0DataRank · unranked

14 citations

Bryan Remaily, Justin Thomas, Kyeongmin Kim, Samuel K. Kulp, Thomas A. Mace +5 more

Physical Activity Delays Obesity-Associated Pancreatic Ductal Adenocarcinoma in Mice and Decreases Inflammation

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.03.521203

N/A

0DataRank · unranked

2 citations

Kelly Dubay, Ali Lahooti, Niharika Badi, Olivia Ueltschi, Kristyn Gumpper +17 more

CD200 is overexpressed in the pancreatic tumor microenvironment and predictive of overall survival

Cancer Immunology Immunotherapy(2024)10.1007/s00262-024-03678-6

N/A

0DataRank · unranked

7 citations

Shrina Jasani, Debasmita Mukherjee, Hannah Lathrop, Priya Matreja, Timothy Pfau +16 more

Systemic Neutrophil Gelatinase-Associated Lipocalin Alterations in Chronic Pancreatitis: A Multicenter, Cross-Sectional Study

Clinical and Translational Gastroenterology(2024)10.14309/ctg.0000000000000686

N/A

0DataRank · unranked

4 citations

Kaylin Chasser, Valentina Pita-Grisanti, Molly Torok, Timothy Pfau, Thomas A. Mace +20 more

Intramuscular CMT‐167 Tumours Produce a Mild Cachexia Phenotype in C57BL/6J Mice

JCSM Communications(2025)10.1002/rco2.117

N/A

0DataRank · unranked

4 citations

Trang T. Vu, Justin Thomas, Kyeongmin Kim, Camille Stanton, Zhiliang Xie +13 more

Tomato-Soy Juice Reduces Inflammation and Modulates Urinary Metabolome in Adults with Obesity

medRxiv(2025)10.1101/2025.09.11.25334465

N/A

0DataRank · unranked

0 citations

J H Miller, Emma A. Bilbrey, Janet A. Novotny, David M. Francis, Thomas A. Mace +2 more

Tomatidine targets ATF4-dependent signaling and induces ferroptosis to limit pancreatic cancer progression

iScience(2023)10.1016/j.isci.2023.107408

N/A

0DataRank · unranked

36 citations

Srija Chakraborty, Lena Bercz, Liliana D’Alesio, Jessica Wedig, Molly Torok +14 more

Lipocalin-2 expression and function in pancreatic diseases

Pancreatology(2020)10.1016/j.pan.2020.01.002

N/A

0DataRank · unranked

29 citations

Andrew W. Dangel, Valentina Pita-Grisanti, Somashekar G. Krishna, Luis F. Lara, Thomas A. Mace +5 more